Transparency Market Research published new market report"Cardiac Prosthetic Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019".The global cardiac prosthetic devices market was valued at USD 2,945.3million in 2012 and is estimated to reach a market worth USD 5,290.0million in 2019at a CAGR of 8.7% from 2013 to 2019.Cardiac prosthetic devices increase the survival rate and improve the quality of life in most patients. These devices are used to replace damaged or diseased natural valves of the heart. The research report on cardiac prosthetic devices provides a detailed analysis of the global market and helps in understanding the driving forces for growth of these devices. The report also provides analysis of major segments such as heart valves (mechanical heart valves, tissue heart valves and transcatheter heart valves) and pacemakers (implantable pacemaker and external pacemaker). Market size estimates and forecasts for the period 2011 to 2019 have been given for each segment and its sub-segments, in terms of USD million, using 2012 as the base year for calculations. Browse the report With Full TOC at http://www.transparencymarketresearch.com/cardiac-prosthetic-market.html

1. Transparency Market Research
Cardiac Prosthetic Devices
Market - Global Industry
Analysis, Size, Share,
Growth, Trends and
Forecast, 2013 - 2019
Buy Now
Request Sample
Published Date: Dec 2013
Single User License: US $ 4795
Multi User License: US $ 7795
80 Pages Report
Corporate User License: US $ 10795
REPORT DESCRIPTION
Cardiac Prosthetic Devices Market is Expected to Reach USD5.3 Billion Globally in
2019: Transparency Market Research
Transparency Market Research is Published new Market Report “Cardiac Prosthetic
Devices Market (Mechanical Heart Valves, Tissue Heart Valves, Transcatheter
Heart Valves, Implantable Pacemaker and External Pacemaker)- Global Industry
Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global cardiac
prosthetic devices market was valued at USD 2,945.3million in 2012 and is estimated to
reach a market worth USD 5,290.0million in 2019at a CAGR of 8.7% from 2013 to 2019.
Cardiac prosthetics are chronic alternatives that replace a damaged or diseased part in the
body.Cardiac prosthetic devices are used in the treatment of blockages in heart valves.
Implantation of these devices is being increasingly accepted as one of the common
procedures due to a rise in the number of patients suffering from valvular diseases.
Prosthetic valve thrombosis (PVT), prosthetic valve endocarditis (PVE), mechanical
hemolytic anemia and thromboembolism are some of the complications that arise from
failure of the primary valves.The growth of cardiac prosthetic devices market is primarily
driven by increasing geriatric population, rise in the number of cardiac diseases (coronary
artery, cardiovascular, peripheral vascular, rheumatic heart, cerebrovascular and valvular

2. heart diseases). In addition, technological advances are also aiding the growth of this
industry.
The cardiac prosthetic devices market can be segmented as heart valves and pacemaker.
Heart valves are further categorized into mechanical heart valves, tissue heart valves and
transcatheter heart valves. The market for cardiac prosthetic devices promises high growth
mainly due to increasing incidence of cardiovascular disorders, rising preference for
minimally-invasive procedures and consistent growth in the geriatric population.
Additionally, a rise in obesity followed by continuous product modification and technological
upgradation resulting in development of effective devices would propel the growth and
uptake of cardiac prosthetic devices. However, high cost of devices, stringent approval
process of these devices (Class III devices) and certain clauses of the Affordable Healthcare
Act (AHA) that contribute in overall increase of the cost of medical devices are some of the
factors that might hamper the growth of the cardiac prosthetic devices market.
At the regional level, North America was the largest market in 2012 for cardiac prosthetic
devices market followed by the European region. Cardiovascular diseases such as valvular
and rheumatic diseases have increased significantly in the developed nations. Furthermore,
a rise in life expectancy of the population has increased the frequency of degenerative valve
diseases. Hence, with the rise in prevalence of these diseases, demand for cardiac
prosthetic devices is expected to increase during the forecast period. Asia-Pacific region is
expected to grow at a higher CAGR of 10.9% from 2013 to 2019. This is majorly due to
large and expanding population base, increased participation of the respective governments
in healthcare sector and rising disposable incomes of the population.
The cardiac prosthetic devices market is characterized by the presence of well-established
players operating in this market. The major companies competing in this market are
Edwards Lifesciences Corporation, Medtronic, Inc., Sorin Group, St. Jude Medical and Boston
Scientific Corporation.
The global cardiac prosthetic devices market is segmented as follows:
Cardiac Prosthetic DevicesMarket, by Segments
Heart Valves

Mechanical Heart Valves

Tissue Heart Valves

Transcatheter Heart Valves
Pacemaker

Implantable Pacemaker

3. 
External Pacemaker
Cardiac Prosthetic Devices Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
Chapter 2 Executive Summary
2.1 Global Cardiac Prosthetic Devices Market, by Segments, 2012 (USD Million)
Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising Geriatric Population
3.2.2 Rising Prevalence of Disorders such as Hypertension, Diabetes and Obesity
3.2.3 Increasing Demand for Minimally-Invasive Procedures
3.3 Market Restraints

4. 3.3.1 Implementation of Affordable Healthcare Act
3.3.2 Strict Approval Process from Government Bodies
3.4 Market Opportunities
3.4.1 Big Opportunities in Emerging Economies with High Unmet Needs
3.4.2 Huge Scope for Alliance with Organizations having Complementary Strength
3.5 Porter’s Five Forces Analysis for the Global Cardiac Prosthetic Devices Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis for the Global Cardiac Prosthetic Devices Market, by
Geography
3.7 Market Share by Key Players of Global Cardiac Prosthetic Devices Market, 2012
3.7.1 Global Cardiac Prosthetic Devices Market Share, by Key Players, 2012 (%)
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/cardiac-prosthetic-market.html
Chapter 4 Cardiac Prosthetic Devices Market, by Segments
4.1 Overview
4.1.1 Global Cardiac Prosthetic Devices Market, by Segments, 2011 – 2019 (USD
Million)
4.2 Heart Valves
4.2.1 Global Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.2 Mechanical Heart Valves
4.2.2.1 Global Mechanical Heart Valves Market, 2011 – 2019 (USD Million)

5. 4.2.3 Tissue Heart Valves
4.2.3.1 Global Tissue Heart Valves Market, by Types, 2011 – 2019 (USD Million)
4.2.3.2 Stented Tissue Valve
4.2.3.2.1 Global Stented Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.3.1 Stentless Tissue Valve
4.2.3.1.1 Global Stentless Tissue Valve Market, 2011 – 2019 (USD Million)
4.2.4 Transcatheter Heart Valves
4.2.4.1 Global Transcatheter Heart Valve Market, 2011 – 2019 (USD Million)
4.3 Pacemaker
4.3.1 Global Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.2 Implantable Pacemaker
4.3.3 Global Implantable Pacemaker Market, by Types, 2011 – 2019 (USD Million)
4.3.3.1 Single-Chamber Battery Pacemaker
4.3.3.1.1 Global Single-Chamber Battery Pacemaker Market, 2011 – 2019
(USD Million)
4.3.3.2 Dual-Chamber Battery Pacemaker
4.3.3.2.1 Global Dual-Chamber Battery Pacemaker Market, 2011 – 2019
(USD Million)
4.3.3.3 Triple-Chamber Battery Pacemaker
4.3.3.3.1 Global Triple-Chamber Battery Pacemaker Market, 2011 – 2019
(USD Million)
4.3.4 External Pacemaker
4.3.4.1 Global External Pacemaker Market, 2011 – 2019 (USD Million)
Chapter 5 Cardiac Prosthetic Devices Market, by Geography
5.1 Overview

6. 5.1.1 Global Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD
Million)
5.2 Comparative Analysis: Cardiac Prosthetic Devices Market, by Geography, 2012 & 2019
(Value %)
5.3 North America
5.3.1 North America Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019
(USD Million)
5.4 Europe
5.4.1 Europe Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD
Million)
5.5 Asia-Pacific
5.5.1 Asia-Pacific Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD
Million)
5.6 Rest of the World (RoW)
5.6.1 RoW Cardiac Prosthetic Devices Market, by Geography, 2011 – 2019 (USD Million)
Related & Recently Published Reports by Transparency Market Research
Wearable Medical Devices Market:
http://www.transparencymarketresearch.com/wearable-medical-devicesmarket.html
Global Lithium Ion Battery Market:
http://www.transparencymarketresearch.com/lithium-ion-battery-market.html
Surface Vision and Inspection Market:
http://www.transparencymarketresearch.com/surface-vision-inspectionmarket.html
Medical Transcription Services Market:
http://www.transparencymarketresearch.com/medical-transcriptionservices.html
Geotextiles and Geogrids Market:
http://www.transparencymarketresearch.com/geotextiles-geogrids-market.html

7. Chapter 6 Recommendations
6.1 Market Strategies for Success
6.2 Barriers to be Considered
Chapter 7 Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Overview
7.1.3 Product Portfolio
7.1.4 Business Strategies
7.1.5 Recent Developments
7.2 Abiomed, Inc.
7.2.1 Company Overview
7.2.2 Financial Overview
7.2.3 Product Portfolio
7.2.4 Business Strategies
7.2.5 Recent Developments
7.3 AtriCure, Inc.
7.3.1 Company Overview
7.3.2 Financial Overview
7.3.3 Product Portfolio
7.3.4 Business Strategies
7.3.5 Recent Developments
7.4 Boston Scientific Corporation

8. 7.4.1 Company Overview
7.4.2 Financial Overview
7.4.3 Product Portfolio
7.4.4 Business Strategies
7.4.5 Recent Developments
7.5 Edward Lifesciences Corporation
7.5.1 Company overview
7.5.2 Financial overview
7.5.3 Product Portfolio
7.5.4 Business Strategies
7.5.5 Recent Developments
7.6 Medtronic, Inc.
7.6.1 Company Overview
7.6.2 Financial Overview
7.6.3 Product Portfolio
7.6.4 Business Strategies
7.6.5 Recent Developments
7.7 Siemens Healthcare
7.7.1 Company Overview
7.7.2 Financial Overview
7.7.3 Product Portfolio
7.7.4 Business Strategies
7.7.5 Recent Developments
7.8 Sorin Group
7.8.1 Company Overview

9. 7.8.2 Financial Overview
7.8.3 Product Portfolio
7.8.4 Business Strategies
7.8.5 Recent Developments
7.9 St. Jude Medical, Inc.
7.9.1 Company Overview
7.9.2 Financial Overview
7.9.3 Product Portfolio
7.9.4 Business Strategies
7.9.5 Recent Developments
About Us:
Transparency Market Research is a market intelligence company providing global business
information reports and services. Our exclusive blend of quantitative forecasting and trends
analysis provides forward-looking insight for thousands of decision makers.
We are privileged with highly experienced team of Analysts, Researchers and Consultants,
who use proprietary data sources and various tools and techniques to gather, and analyze
information. Our business offerings represent the latest and the most reliable information
indispensable for businesses to sustain a competitive edge.
Contact:
Transparency Market Research
90 State Street,
Suite 700, Albany,NY – 12207,
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/
Browse the full report with complete TOC at
http://www.transparencymarketresearch.com/cardiac-prosthetic-market.html